Skip to main content
lexblog.com/lib/3XTXWVGRviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "S.D. Texas:  PMA Preemption and <em>Twiqbal</em> Doom Stent Graft Warnings and Manufacturing Defect Claims",
    "url": "https://www.lexblog.com/2023/04/28/s-d-texas-pma-preemption-and-twiqbal-doom-stent-graft-warnings-and-manufacturing-defect-claims/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-3XTXWVGR",
        "url": "https://www.lexblog.com/lib/3XTXWVGR/"
    },
    "datePublished": "2023-04-28T04:00:00-04:00",
    "dateModified": "2023-04-28T05:10:24-04:00",
    "author": {
        "@type": "Person",
        "name": "Rachel B. Weil"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Drug & Device Law Blogging Team"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Drug & Device Law",
    "about": "Business and Commercial",
    "sourceUrl": "https://www.druganddevicelawblog.com/?p=41742",
    "sourceStability": "may-move"
}